Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AI Labs Group S.L
Brain Inflammation Collaborative
Cairo University
Brigham and Women's Hospital
Bristol-Myers Squibb
M.D. Anderson Cancer Center
Amgen
Leiden University Medical Center
ProgenaBiome
Pfizer
HJN Sverige AB/Neko Health
University of California, Davis
Bristol-Myers Squibb
Centre Hospitalier Universitaire Vaudois
Akdeniz University
University of California, San Diego
University of California, San Diego
VitaMed Research LLC
Amgen
Sanguine Biosciences
Sanguine Biosciences
Global Healthy Living Foundation
University of California, Irvine
Alliance Foundation Trials, LLC.
Icahn School of Medicine at Mount Sinai
Erasmus Medical Center
University of Alabama at Birmingham
Biocad
Novartis
Mayo Clinic
University of Southern Denmark
Harvard School of Public Health (HSPH)
Eli Lilly and Company
Eli Lilly and Company
University of California, San Francisco
Pfizer
Novartis
University of California, Davis
MetrioPharm AG
Mayne Pharma International Pty Ltd
Pfizer
Pfizer
Tianjin Ever Union Biotechnology Co., Ltd.
AbbVie
University of Alabama at Birmingham
Medical University of Graz
Tufts Medical Center
Pfizer
Amgen